logo
logo

Summit Receives Investment from U. of Colorado Anschutz Medical Campus CDI Fund

Summit Receives Investment from U. of Colorado Anschutz Medical Campus CDI Fund

11/18/20, 4:19 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgaurora
Summit Biolabs, an early-stage molecular diagnostics company specializing in saliva liquid-biopsy tests for COVID-19 and head and neck cancer, announced they have received funding from the University of Colorado Anschutz Medical Campus (CU Anschutz), Chancellor Discovery Innovation Fund (CDI Fund).

Company Info

Company
Summit Biolabs
Location
aurora, colorado, united states
Additional Info
Summit Biolabs is harnessing the power of saliva-based diagnostics to address critical challenges in COVID-19 and head & neck cancer testing. Founded on the discoveries of Dr. Shi-Long Lu, Summit Biolabs is being spun out from the University of Colorado Anschutz Medical Campus.